Competitor COVID spray sales halted

I found this article online today but can only provide the summary as the full article can only be accessed if you subscribe.

Executive Summary:
‘Starpharma's COVID-busting Viraleze antiviral nasal spray will soon be available across Europe, included the UK. But will it fall foul of local evidence requirements, for example in France, where the country's medicines agency has halted the sale of Pharma & Beauty (P&B) Group's COV-Defense spray until its efficacy against COVID has been confirmed by human-based studies?’

https://hbw.pharmaintelligence.informa.com/RS151051/Australias-Starpharma-Plans-To-Launch-COVID-Killing-Nasal-Spray-In-Europe

This second link is to the initial article I first posted on another thread a few weeks ago highlighting this potential competitor to Starpharma and Viraleze. The article is titled: French Nasal Spray eliminates 99% of Covid virus.

https://www.connexionfrance.com/French-news/New-French-nose-spray-eliminates-99-of-Covid-virus-via-nose-blowing

Lastly, this third link is to an article I found late today and is regarding the suspension titled: French made Covid nasal spray suspended due to lack of safety data. Of note the full article indicates the French regulator had issues with the fact there was no data supporting its performance or safety.

https://www.thelocal.fr/20210224/french-made-covid-nasal-spray-suspended-due-to-lack-of-safety-data/

Of note, I’m not fully informed of what regulatory approvals this product had before commencing sales in pharmacies etc. I can only assume that it likely gained ‘registration’ just like Viraleze has, and makes claims about effectiveness against Covid just like Viraleze has, and has subsequently been halted in France. But I don’t know. I’m not sure if this has parallel implications for Starpharma or not. Just sharing what I’ve come across to other forum members to consider or research further.